1. Home
  2. EJH vs QUCY Comparison

EJH vs QUCY Comparison

Compare EJH & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo E-Home Household Service Holdings Limited

EJH

E-Home Household Service Holdings Limited

HOLD

Current Price

$1.52

Market Cap

5.2M

ML Signal

HOLD

Logo Mainz Biomed N.V. Ordinary Shares

QUCY

Mainz Biomed N.V. Ordinary Shares

N/A

Current Price

$0.36

Market Cap

5.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EJH
QUCY
Founded
2018
2008
Country
China
Germany
Employees
N/A
13
Industry
Other Consumer Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
5.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
EJH
QUCY
Price
$1.52
$0.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.7K
499.5K
Earning Date
05-18-2026
06-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$74.34
Revenue Next Year
N/A
$171.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.37
52 Week High
$12.45
$0.74

Technical Indicators

Market Signals
Indicator
EJH
QUCY
Relative Strength Index (RSI) 53.07 33.73
Support Level $0.96 N/A
Resistance Level $1.62 $0.54
Average True Range (ATR) 0.10 0.05
MACD -0.06 -0.01
Stochastic Oscillator 15.30 6.89

Price Performance

Historical Comparison
EJH
QUCY

About EJH E-Home Household Service Holdings Limited

E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving orders online and providing services offline. Its operations are organized into four reportable segments: appliance installation and maintenance services, housekeeping services, senior care services, and educational consulting services. The company generates the majority of its revenue from installation and maintenance.

About QUCY Mainz Biomed N.V. Ordinary Shares

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Share on Social Networks: